GREY:NPCUF - Post by User
Comment by
diadon1945on Dec 13, 2012 12:28am
176 Views
Post# 20723326
RE: RE: RE: RE: RE: Kickinghorse
RE: RE: RE: RE: RE: Kickinghorse I strongly believe PPHM's Bavituximab works..but you must wait for trial results...and they have 3 phase 2 trials reporting in the next few months...and probably increasing Median Overall Survival by 80-100%. They have 9 trials all in the $90 billion cancer market. Bavi works by reviving and unblocking the natural immune system and works well in combination therapy with drugs and radiation in all the solid tumours(Lung,Pancreatic,Liver,Prostate,Rectal,Ovarian etc.etc.) in which it has been tested.
Allon is going after PSP as part of the $3-4 billion frontotemperal dementia market as the first indication. But they have also done a phase 1 in Parkinsons,and a phase 2a in both Alzheimers and Schizophrenia. All together these could be another $20-30 billion. It is hard to estimate the market size because up to this point most treatments have only dealt with symptoms and not the underlying pathology the way Davunitide does. I can see Davi as part of a combination therapy other new emerging technologies. But there again we must await the results. We shall soon know...the diseases it treats are horrendous. I pray it works! If the results are good the share price will be many times the current price!
In both cases partnerships are close at hand...and that will increase the share price! And in both cases the companies could be taken over by Big Pharma! And that would increase the share price even more! Good Luck to all Longs!